ArticleMolecular medicine (Cambridge, Mass.)2026
Dehydrocorydaline treatment suppresses Th17 differentiation via the mTOR-mediated STAT3-RORγt signaling in systemic lupus erythematosus.
Jiena Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.